| Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis D Pascual-Salcedo, C Plasencia, S Ramiro, L Nuno, G Bonilla, D Nagore, ... Rheumatology 50 (8), 1445-1452, 2011 | 322 | 2011 |
| Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab C Plasencia, D Pascual-Salcedo, L Nuño, G Bonilla, A Villalba, ... Annals of the rheumatic diseases 71 (12), 1955-1960, 2012 | 169 | 2012 |
| Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars MB Ruiz-Argüello, A Maguregui, AR Del Agua, D Pascual-Salcedo, ... Annals of the Rheumatic Diseases 75 (9), 1693-1696, 2016 | 93 | 2016 |
| Serum oxidizability and antioxidant status in patients undergoing in vitro fertilization I Aurrekoetxea, JI Ruiz-Sanz, AR Del Agua, R Navarro, ML Hernández, ... Fertility and sterility 94 (4), 1279-1286, 2010 | 63 | 2010 |
| Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels B Ruiz-Argüello, AR del Agua, N Torres, A Monasterio, A Martínez, ... Clinical Chemistry and Laboratory Medicine (CCLM) 51 (12), e287-e289, 2013 | 53 | 2013 |
| Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR JI Ruiz-Sanz, I Aurrekoetxea, AR del Agua, MB Ruiz-Larrea Molecular and cellular probes 21 (3), 202-207, 2007 | 35 | 2007 |
| EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research C Beyer, JHW Distler, Y Allanore, M Aringer, J Avouac, L Czirják, ... Annals of the rheumatic diseases 70 (7), 1178-1182, 2011 | 31 | 2011 |
| Optimal concentration range of golimumab in patients with axial spondyloarthritis A Martínez-Feito, C Plasencia-Rodriguez, V Navarro-Compán, T Jurado, ... Clin Exp Rheumatol 36 (1), 110-114, 2018 | 15 | 2018 |
| Tumor tissue microarrays for rapid molecular profiling J Kononen, S Leighton, OP Kallioniemi US Patent App. 10/215,762, 2002 | 15 | 2002 |
| Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases S Martín, AR del Agua, N Torres, D Pascual-Salcedo, C Plasencia, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (11), e297-e299, 2015 | 13 | 2015 |
| Cost-Effectiveness of therapeutic drug monitoring-guided adalimumab therapy in rheumatic diseases: a prospective, pragmatic trial C Gómez-Arango, I Gorostiza, E Úcar, ML García-Vivar, CE Pérez, ... Rheumatology and Therapy 8, 1323-1339, 2021 | 7 | 2021 |
| Optimal concentration range of ustekinumab in patients with plaque-type psoriasis S Martín-González, P Urigoitia-Ugalde, J Careaga, D Nagore, R Navarro, ... Journal of the American Academy of Dermatology 80 (6), 1782-1784, 2019 | 5 | 2019 |
| SAT0150 prospective, intervention, multicenter study of utility of biologic drug monitoring with respect to the efficacy and cost of adalimumab tapering in patients with … E Ucar, Í Gorostiza, C Gόmez, CE Pérez, JR De Dios, B Alvárez, A Ruibal, ... Annals of the Rheumatic Diseases 76 (Suppl 2), 826-826, 2017 | 4 | 2017 |
| Tu1325 Therapeutic cut-off of infliximab in patients with inflammatory bowel diseases D Nagore, AR del Agua, J Pascual, F Llinares-Tello, B Herreros, ... Gastroenterology 148 (4), S-860, 2015 | 4 | 2015 |
| Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases K Papamichael, G Stocco, AR Del Agua Therapeutic Drug Monitoring 45 (5), 579-590, 2023 | 3 | 2023 |
| Monitoring of anti-TNF biological treatments A Ruiz del Agua, D Pascual-Salcedo, A Balsa, I Ramos, L Novalbos, ... Journal of Translational Medicine 8 (Suppl 1), P32, 2010 | 3 | 2010 |
| Prospective, intervention, multicenter, non-inferiority study of utility of therapeutic drug monitoring with respect to the efficacy and cost of adalimumab tapering in patients … C Gomez Arango, ML Garcia Vivar, E Ucar Angulo, I Gorostiza, ... ARTHRITIS & RHEUMATOLOGY 69, 2017 | 2 | 2017 |
| Prospective, intervention, multicenter study of utility of biologic drug monitoring with respect to the efficacy and cost of adalimumab tapering in patients with rheumatic … I Gorostiza, E Ucar Angulo, C Gomez Arango, C Eugenia Perez, ... ARTHRITIS & RHEUMATOLOGY 68, 2016 | 1 | 2016 |
| PTU-087 Therapeutic cut-off of infliximab in patients with inflammatory bowel diseases D Nagore, AR del Agua, J Pascual, F Llinares-Tello, B Herreros, ... Gut 64 (Suppl 1), A99-A99, 2015 | 1 | 2015 |
| Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy AR del Agua, I Aurrekoetxea, MA Elorriaga, F Rodriguez, F Guéraud, ... Menopause 18 (5), 575-581, 2011 | 1 | 2011 |
